First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy
In 2017, a clinical trial of 37 subjects demonstrated that preschool peanut oral immunotherapy (P-OIT) was safe, with predominantly mild symptoms reported and only 1 moderate reaction requiring epinephrine. We sought to examine whether these findings would be applicable in a real-world setting. As p...
Saved in:
Published in | The journal of allergy and clinical immunology in practice (Cambridge, MA) Vol. 7; no. 8; p. 2759 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.11.2019
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!